Your browser doesn't support javascript.
loading
A phase 1b randomised, placebo-controlled trial of nabiximols cannabinoid oromucosal spray with temozolomide in patients with recurrent glioblastoma.
Twelves, Chris; Sabel, Michael; Checketts, Daniel; Miller, Sharon; Tayo, Bola; Jove, Maria; Brazil, Lucy; Short, Susan C.
Afiliação
  • Twelves C; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Sabel M; Department of Oncology, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Leeds, UK.
  • Checketts D; Department of Neurosurgery, Heinrich-Heine-University, Dusseldorf, Germany.
  • Miller S; GW Research Ltd., Sovereign House, Vision Park, Chivers Way, Histon, Cambridge, UK.
  • Tayo B; GW Research Ltd., Sovereign House, Vision Park, Chivers Way, Histon, Cambridge, UK.
  • Jove M; GW Research Ltd., Sovereign House, Vision Park, Chivers Way, Histon, Cambridge, UK.
  • Brazil L; Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.
  • Short SC; Guy's and St Thomas Hospitals Cancer Centre, Guys Hospital, Great Maze Pond, London, UK.
Br J Cancer ; 124(8): 1379-1387, 2021 04.
Article em En | MEDLINE | ID: mdl-33623076
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article